JUNE 28 - JULY 2, 2020  
30 years of Care Transitions Across the Full Continuum

PP101 – Beyond Blood Thinners: Options in the Prevention of Stroke Related to Atrial Fibrillation

PP101 – Beyond Blood Thinners: Options in the Prevention of Stroke Related to Atrial Fibrillation

The most serious complication of atrial fibrillation is a stroke—which can be life threatening. People with atrial fibrillation (not caused by a valve problem) are five (5) times more likely to have a stroke.

Historically warfarin (Coumadin)and aspirin have been used to help prevent strokes due to chronic atrial fibrillation (not related to a valve issue).   Xarelto, Pradaxa, and Eliquis are newer medications that can be used in stroke prevention. A new implantable device, Watchman, is proving to be effective as well. Which option is best for your patient? Does the patient’s lifestyle, occupation or other health conditions put them at risk for complications from blood thinners? Do they have the resources for regular INR checks?  Are they compliant with food and drink restrictions, regular blood testing and timely medication administration? Would a permanent implantable device be a good option? How does the permanent implantable device work?

It is important for case managers to understand the options available to reduce the risk of stroke due to atrial fibrillation. This presentation will compare these options. Risks, benefits and mechanisms of action for each option will be discussed as well as follow up care, restrictions, and costs.  Pertinent patient teaching points related to all the options will be included.